Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 3 | 2025 | 123 | 1.130 |
Why?
|
| Drug Overdose | 3 | 2021 | 58 | 0.940 |
Why?
|
| Prescriptions | 2 | 2023 | 29 | 0.870 |
Why?
|
| Radiculopathy | 1 | 2023 | 5 | 0.860 |
Why?
|
| Musculoskeletal Pain | 1 | 2023 | 24 | 0.840 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 246 | 0.740 |
Why?
|
| Maltose-Binding Proteins | 2 | 2017 | 2 | 0.700 |
Why?
|
| Quality of Life | 1 | 2023 | 505 | 0.670 |
Why?
|
| Vietnam | 7 | 2025 | 40 | 0.660 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 13 | 0.570 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 424 | 0.470 |
Why?
|
| Criminal Law | 3 | 2020 | 13 | 0.470 |
Why?
|
| Prisoners | 3 | 2020 | 53 | 0.430 |
Why?
|
| Caregivers | 2 | 2025 | 130 | 0.430 |
Why?
|
| Humans | 16 | 2025 | 17376 | 0.410 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 1287 | 0.370 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2023 | 311 | 0.350 |
Why?
|
| Recidivism | 2 | 2019 | 3 | 0.300 |
Why?
|
| Adult | 8 | 2025 | 7529 | 0.280 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 2 | 0.270 |
Why?
|
| Escherichia coli | 2 | 2017 | 8 | 0.270 |
Why?
|
| Male | 8 | 2025 | 9843 | 0.260 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2428 | 0.260 |
Why?
|
| Female | 9 | 2025 | 12444 | 0.250 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 49 | 0.230 |
Why?
|
| Headache | 1 | 2023 | 14 | 0.220 |
Why?
|
| Back Pain | 1 | 2023 | 32 | 0.210 |
Why?
|
| Olfaction Disorders | 1 | 2023 | 1 | 0.210 |
Why?
|
| Smell | 1 | 2023 | 3 | 0.210 |
Why?
|
| Needs Assessment | 1 | 2023 | 68 | 0.210 |
Why?
|
| Stress, Psychological | 1 | 2024 | 133 | 0.210 |
Why?
|
| Aged | 5 | 2025 | 6129 | 0.200 |
Why?
|
| Outpatients | 1 | 2023 | 101 | 0.200 |
Why?
|
| Prisons | 2 | 2020 | 29 | 0.190 |
Why?
|
| Young Adult | 4 | 2025 | 2473 | 0.190 |
Why?
|
| Consumer Health Informatics | 1 | 2020 | 1 | 0.170 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 11 | 0.170 |
Why?
|
| Health Personnel | 1 | 2021 | 126 | 0.170 |
Why?
|
| Mass Screening | 1 | 2025 | 671 | 0.160 |
Why?
|
| Colorado | 1 | 2020 | 164 | 0.160 |
Why?
|
| Rubella Vaccine | 1 | 2019 | 9 | 0.160 |
Why?
|
| Judicial Role | 1 | 2019 | 2 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.160 |
Why?
|
| Violence | 1 | 2019 | 28 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 366 | 0.150 |
Why?
|
| Adolescent | 3 | 2025 | 3533 | 0.150 |
Why?
|
| Vaccination Coverage | 1 | 2019 | 52 | 0.150 |
Why?
|
| Prokaryotic Cells | 1 | 2017 | 1 | 0.140 |
Why?
|
| Thioredoxins | 1 | 2017 | 1 | 0.140 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2017 | 1 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 285 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1155 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 5 | 0.130 |
Why?
|
| Incidence | 1 | 2020 | 1266 | 0.130 |
Why?
|
| Middle Aged | 5 | 2025 | 7885 | 0.110 |
Why?
|
| Child | 1 | 2020 | 2382 | 0.100 |
Why?
|
| Michigan | 2 | 2020 | 28 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1942 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 677 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 7 | 0.060 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2025 | 14 | 0.060 |
Why?
|
| Vaccines, Synthetic | 1 | 2025 | 36 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2025 | 142 | 0.060 |
Why?
|
| Culturally Competent Care | 1 | 2024 | 11 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 66 | 0.060 |
Why?
|
| Odorants | 1 | 2023 | 3 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 2526 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 367 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 19 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.040 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2019 | 1 | 0.040 |
Why?
|
| Occupations | 1 | 2019 | 15 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 33 | 0.040 |
Why?
|
| Rubella | 1 | 2019 | 7 | 0.040 |
Why?
|
| Public Policy | 1 | 2019 | 14 | 0.040 |
Why?
|
| Parity | 1 | 2019 | 57 | 0.040 |
Why?
|
| Rural Population | 1 | 2019 | 55 | 0.040 |
Why?
|
| Educational Status | 1 | 2019 | 179 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 109 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 151 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 174 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 1 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 1 | 0.030 |
Why?
|
| Plasmids | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cricetinae | 1 | 2016 | 2 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 7 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 23 | 0.030 |
Why?
|
| Animals | 1 | 2016 | 280 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 1466 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 3255 | 0.030 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->